the First clinical trials of a vaccine against the coronavirus will hold on 60 volunteers. This was reported by General Director of state scientific center “Vector” Rinat Maksyutov.
According to him, the list of volunteers formed, among them are some of the developers of vaccines. Among them is the chief developer Ilnaz Gimatdinov, told native in the film naili Asker-zade “Threat virus 2” in the channel “Russia 1”.
As said General Director of “Vector”, clinical trials are conducted on healthy volunteers in accordance with the approved Protocol.
on the Eve of “Vector” registered test system on the detection of antibodies to the new coronavirus.
a New diagnostic tool will allow you to identify retrospectively recover, to study immunity and to assess the effectiveness of the developed vaccines against COVID-19.
as at 11 April in Russia since the beginning of the epidemic was 13 584 cases of infection with coronavirus in 82 regions. In this case only from the infection died 106 patients and was cured ― 1045.
